Medico Remedies Ltd

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 10th February 2023 has inter alia considered and approved the Quarterly Unaudited Standalone<BR> Financial Results of the Company for the Quarter and Nine Months ended 31st December 2022 along with the Limited Review Report thereon. (enclosed)